Pay in 4 interest-free payments of $7.18 Learn more
Ships within 48 hours · Estimated delivery Aug 7 - Aug 12
Clinical Evidence Results from the Hairgenetix 150-day clinical trial and published peer-reviewed research The Hairgenetix clinical trial In a 150-day clinical trial involving 30 men and women aged 1865 with various types of hair loss, the Hairgenetix serum achieved: 93% reduction in hair shedding (pull test) 75% of participants reported visible new growth by day 90 70% improvement in hair density (trichoscopy) 90% satisfaction rate at trial completion All participants used the Meso-Infusion System as directed, with assessments at 30, 60, 90, 120, and 150 days under medical supervision
The reaction of rat mast cells to polylysine
All content is provided for research and educational purposes only and does not constitute medical, pharmaceutical, or legal advice
Rees DD, Palmer RM, Moncada S: Role of endothelium-derived nitric oxide in the regulation of blood pressure
Given the objective of this article as a narrative and mechanistic integrative review, formal quantitative synthesis or meta-analysis was not undertaken
Nanocarrier synthesis Synthesis of 3-armed poly(-benzyl-l-glutamic acid) (3-PBLG) In this study, tris(2-aminoethyl)amine was used as a 3-armed initiator for the ring-opening polymerization method to synthesize 3-armed poly(-benzyl-l-glutamic acid) (3-PBLG) [43,44,45] (Fig
US$ 28.17
US$ 28.62
US$ 24.52
US$ 24.08
US$ 24.10
US$ 21.74